Phosphorylated dihydroceramides from common human bacteria are recovered in human tissues

PLoS ONE

Volumn 6, Issue 2, 2011, Pages

  Nichols, Frank C ^a   Yao, Xudong ^b   Bajrami, Bekim ^b   Downes, Julia ^c   Finegold, Sydney M ^c   Knee, Erica ^a   Gallagher, James J ^d,e   Housley, William J ^d   Clark, Robert B ^d  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF DENTAL MEDICINE   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

^c VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^d UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^e Department of Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE DERIVATIVE; DIHYDROCERAMIDE DERIVATIVE; TOLL LIKE RECEPTOR 2; UNCLASSIFIED DRUG; CERAMIDE; DIHYDROCERAMIDE;

ARTICLE; BACTEROIDES; BLOOD VESSEL; BRAIN TISSUE; CONTROLLED STUDY; GINGIVA; HUMAN; HUMAN TISSUE; INTESTINE FLORA; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIPOGENESIS; MOUTH FLORA; NONHUMAN; PARABACTEROIDES; PHOSPHORYLATION; PORPHYROMONAS; PREVOTELLA; TANNERELLA; TISSUE LEVEL; TISSUE SPECIFICITY; ANTIBODY SPECIFICITY; ARTERY; ATHEROSCLEROTIC PLAQUE; BACTERIUM; BRAIN; INTESTINE; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; PERIODONTIUM; PLASMA;

BACTEROIDES; MAMMALIA; MURINAE; PORPHYROMONAS; PORPHYROMONAS GINGIVALIS; PREVOTELLA; TANNERELLA;

ARTERIES; BACTERIA; BRAIN; CERAMIDES; HUMANS; INTESTINES; ORGAN SPECIFICITY; PERIODONTIUM; PHOSPHORYLATION; PLAQUE, ATHEROSCLEROTIC; PLASMA; TOLL-LIKE RECEPTOR 2;

EID: 79951832883     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016771     Document Type: Article

References (21)

1. Nichols FC, Riep B, Mun J, Morton MD, Bojarski MT, et al. (2004) Structures and biological activity of phosphorylated dihydroceramides of Porphyromonas gingivalis. J Lipid Res 45: 2317-2330.
2. Nichols FC, Housley WJ, O'Conor CA, Manning T, Wu S, et al. (2009) Unique lipids from a common human bacterium represent a new class of Toll-like receptor 2 ligands capable of enhancing autoimmunity. Am J Pathol 175: 2430-2438.
3. Wang YH, Jiang J, Zhu Q, Alanezi AZ, Clark RB, et al. (2010) Porphyromonas gingivalis lipids inhibit osteoblastic differentiation and function. Infect Immun 78: 3726-3735.
4. Zahlten J, Riep B, Nichols FC, Walter C, Schmeck B, et al. (2007) Porphyromonas gingivalis dihydroceramides induce apoptosis in endothelial cells. J Dent Res 86: 635-640.
5. Nichols FC, Rojanasomsith K, (2006) Porphyromonas gingivalis lipids and diseased dental tissues. Oral Microbiol Immunol 21: 84-92.
6. Clarke TB, Davis KM, Lysenko ES, Zhou AY, Yu Y, et al. (2010) Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nat Med 16: 228-231.
7. Philpott DJ, Girardin SE, (2010) Gut microbes extend reach to systemic innate immunity. Nat Med 16: 160-161.
8. Fukami H, Tachimoto H, Kishi M, Kaga T, Waki H, et al. (2010) Preparation of 13C-labeled ceramide by acetic acid bacteria and its incorporation in mice. J Lipid Res.
9. Aumeunier A, Grela F, Ramadan A, Pham Van L, Bardel E, et al. (2010) Systemic Toll-like receptor stimulation suppresses experimental allergic asthma and autoimmune diabetes in NOD mice. PLoS One 5: e11484.
10. Mazmanian SK, Kasper DL, (2006) The love-hate relationship between bacterial polysaccharides and the host immune system. Nat Rev Immunol 6: 849-858.
11. Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL, (2005) An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122: 107-118.
12. Round JL, Mazmanian SK, (2009) The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 9: 313-323.
13. Round JL, O'Connell RM, Mazmanian SK, (2010) Coordination of tolerogenic immune responses by the commensal microbiota. J Autoimmun 34: J220-225.
14. Wen L, Ley RE, Volchkov PY, Stranges PB, Avanesyan L, et al. (2008) Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 455: 1109-1113.
15. Arkema EV, Karlson EW, Costenbader KH, (2010) A Prospective Study of Periodontal Disease and Risk of Rheumatoid Arthritis. J Rheumatol.
16. de Pablo P, Chapple IL, Buckley CD, Dietrich T, (2009) Periodontitis in systemic rheumatic diseases. Nat Rev Rheumatol 5: 218-224.
17. de Pablo P, Dietrich T, McAlindon TE, (2008) Association of periodontal disease and tooth loss with rheumatoid arthritis in the US population. J Rheumatol 35: 70-76.
18. Mikuls TR, Payne JB, Reinhardt RA, Thiele GM, Maziarz E, et al. (2008) Antibody responses to Porphyromonas gingivalis (P. gingivalis) in subjects with rheumatoid arthritis and periodontitis. Int Immunopharmacol.
19. Pischon N, Pischon T, Kroger J, Gulmez E, Kleber BM, et al. (2008) Association among rheumatoid arthritis, oral hygiene, and periodontitis. J Periodontol 79: 979-986.
20. Bligh EG, Dyer WJ, (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37: 911-917.
21. Garbus J, DeLuca HF, Loomas ME, Strong FM, (1968) Rapid incorporation of phosphate into mitochondrial lipids. J Biol Chem 238: 59-63.